September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Neutralization of Fibroblast Growth Factor-2 (FGF-2) Suppresses HSV-1-induced Corneal Lymphangiogenesis
Author Affiliations & Notes
  • Hem Raj Gurung
    Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Daniel J Carr
    Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Footnotes
    Commercial Relationships   Hem Gurung, None; Daniel Carr, None
  • Footnotes
    Support  R01 EY021238
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 329. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hem Raj Gurung, Daniel J Carr; Neutralization of Fibroblast Growth Factor-2 (FGF-2) Suppresses HSV-1-induced Corneal Lymphangiogenesis. Invest. Ophthalmol. Vis. Sci. 2016;57(12):329.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : The genesis of lymphatic vessels (lymphangiogenesis) is induced in murine cornea following herpes simplex virus type 1 (HSV-1) infection. Lymphangiogenesis progresses and is maintained well past the resolution of infection by unknown means. Previous studies by our group suggest infiltrating leukocytes do not play a role. The present study was undertaken to identify the contribution of pro-angiogenic factors that promote and sustain lymphangiogenesis past virus clearance.

Methods : C57BL6/J mice were infected with 500-1,000 plaque forming units (PFU) of HSV-1 per eye. Ten mg/kg dexamethasone (DEX) or vehicle was administered by intraperitoneal injection at day 10 pi. FGF-2 and IL-6 were neutralized in vivo by subconjunctival injections of anti-FGF-2 or anti-IL-6 monoclonal antibodies respectively on days 8, 10, and 12 pi. Mice were euthanized at day 14 and day 21 pi, and the corneas were removed and processed. Corneal lymphatic vessels (LYVE-1+) and blood vessels (CD31+) were visualized by confocal microscopy following immunohistochemical staining. Pro-angiogenic protein (angiopoietin-2, FGF-2, hepatocyte growth factor, interleukin [IL]-1, IL-6, matrix metalloproteinase 9, tumor necrosis factor [TNF]-α, vascular endothelial growth factor [VEGF]-A, and VEGF-C) levels were determined by bioplex multiplex array or ELISA at times pi. Data were analyzed by ANOVA and Tukey’s multiple comparisons test.

Results : A single bolus of DEX at day 10 pi resulted in a significant reduction of blood vessel genesis (hemangiogenesis) at day 14 pi and blood and lymphatic vessel development into the cornea at day 21 pi compared to control-treated mice. Among factors identified in the cornea at times pi impacted by DEX, we focused on FGF-2 and IL-6. Whereas IL-6 neutralization had a modest impact on hemangiogenesis (day 14-21 pi) and lymphangiogenesis (day 21 pi) in a time-dependent fashion, neutralization of FGF-2 had a more pronounced effect in suppressing neovascularization (blood and lymphatic vessels) in total in a time-dependent manner.

Conclusions : A single bolus of DEX at the time of HSV-1 clearance completely reverses the incidence of angiogenesis in the cornea of mice. This process was recapitulated by antibody-mediated neutralization of FGF- 2.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.